FB Financial (NYSE:FBK) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.79 by 7.59 percent. This is a 4.49 percent decrease over earnings of $0.89 per share from the same period last year.
BriaCell Extends Personalized Breast Cancer Immunotherapy To Prostate & Lung Cancer And Melanoma
BriaCell Therapeutics Corp (NASDAQ:BCTX) has advanced its targeted oncology therapeutics into several novel immunotherapy cell lines, including – Bria-Pros for prostate…